Hepatitis B Virus Core Antigen (HBcAg) Antikörper

Produktnummer ABIN111727

Dieses Maus Monoklonal-Antikörper erkennt spezifisch in WB, IF, EIA und IHC (fro). Er zeigt eine Reaktivität gegenüber Hepatitis B Virus (HBV).

Kurzübersicht für Hepatitis B Virus Core Antigen (HBcAg) Antikörper (ABIN111727)

Target: Hepatitis B Virus Core Antigen (HBcAg)

Reaktivität: Hepatitis B Virus (HBV)

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF), Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro))

Klon: C1

Produktdetails

Aufreinigung: Protein A chromatography.

Immunogen: Recombinant HBcAg core antigen (ayw)

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: Immunofluorescent and immunoperoxidase staining of infected liver tissues andHBV-transfected hepatoma cells. Immuno electron microscopy. Western blot. ELISA.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1 mg/mL

Buffer: PBS without preservatives.

Konservierungsmittel: Without preservative

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Antigendetails

Target: Hepatitis B Virus Core Antigen (HBcAg)

Andere Bezeichnung: Hepatitis B Core Antigen / HBcAg

Substanzklasse: Viral Protein

Hintergrund: Hepatitis B Virus Core Antigen (HBcAg) is part of the infectious virion containing an inner "core particle" enclosing the viral genome. The icosahedral core particle contains 180 or 240 copies of the core protein. HBcAg is one of the three major clinical antigens of hepatitis B virus but disappears early in the course of infection. The hepatitis B virus core antigen (HBcAg) is a highly immunogenic subviral particle and functions as both a T-cell-dependent and a T-cell-independent antigen. Therefore, HBcAg may be a promising candidate target for therapeutic vaccine control of chronic HBV infection.Synonyms: HBV Capsid protein, HBV Core protein, p21.5